BOSTON — Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the development of next-generation cancer cell therapies. The collaboration will […]

ROCKVILLE, Md. — Multiomics CRO Psomagen is thrilled to announce the launch of Spatial Biology services for 10X Genomics Xenium™. This platform is reshaping spatial biology, enabling researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. This marks a pivotal moment in the scientific community’s access to spatial genomics. According to Psomagen […]

Ann Arbor, MI – Akadeum Life Sciences, the global leader in buoyancy-based cell separation, have today announced Jim Militello as their new Chief Financial Officer (CFO), effective September 12, 2023. Jim will play a key role in overseeing the fundraising, financial analysis and strategic planning of Akadeum as it continues its rapid growth in a market set […]

First-in-class analytical solution quickly detects intended and unintended edits in engineered cells at single-cell resolution, enabling safer therapies and better disease modeling SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, today launched the Tapestri® Genome Editing Solution. Designed to meet the pressing need for high-resolution analysis of genome […]

WATERTOWN, Mass. — Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical Sciences […]

Oberkochen, Germany  — After more than 20 years at ZEISS, the Chief Financial Officer (CFO) of Carl Zeiss AG, Dr. Christian Müller, has decided not to extend his contract for another term. He has informed the Supervisory Board and will leave the company at his own request on 30 September 2023. “ZEISS continues its dynamic, […]

InSphero and Darwin Microfluidics signed distribution agreement to facilitate purchasing InSphero’s 3D in vitro products within the European Union Zurich, Switzerland – InSphero today announced that the company is making their 3D in vitro products available to researchers in the European Union market more easily by signing a distribution agreement with Darwin Microfluidics, an innovative startup dedicated to bringing advanced microfluidic solutions […]

A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions found inside a cell. These conditions are essential for maintaining the native conformation and normal activity of these proteins. To address this critical issue, Celtarys and G.CLIPS are thrilled […]

At Stratedigm, our vision has always been to build lasting flow cytometers and nurture lasting partnerships. Today, we are excited to introduce our newest customer care program. Named Flowraissance™ (FLOW-rah-sahns) in the spirit of the ideals of revival, exploration, and intellectual and scientific progress, the program aims to breathe new life into your trusted S1000 flow cytometer, empowering you […]

CARLSBAD, Calif. — Navigate BioPharma Services, Inc., a Novartis subsidiary, a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and […]